Investigative Sites Rate INC Research, Inc., PPD, Inc., inVentiv Health Top CROs in New CenterWatch Study
Published: May 01, 2013
Investigative sites gave the highest ratings to their clinical trial relationships with INC Research, PPD and inVentiv Health Clinical. These CROs received top average ratings across 36 relationship attributes evaluated in CenterWatch’s bi-annual 2013 Global Investigative Site Relationship survey. In the fourth spot was Covance, followed by Quintiles, PRA, Parexel and Icon.
According to the results, CRO effectiveness overall in managing their relationships with sites has declined slightly over the past two years, and the average CRO rating has fallen below performance expectations in several critical areas, including protocol/study design planning and project support.
“Sites want to voice their opinions and share insights with sponsors and CROs on areas in which progress has been made, along with areas that may need improvement,” said Joan Chambers, COO of CenterWatch. “Sponsors and CROs take this feedback very seriously given its importance to successful global clinical trial performance. These insights provide sponsors and CROs the opportunity to work with their internal teams to strengthen and enhance their site relationships.”
The survey also asked sites to evaluate CROs on their overall reputation in the industry. Sites gave the top ranking to PPD, followed by Covance, Quintiles, Icon and INC Research.
The CenterWatch 2013 Global Investigative Site Relationship Survey was conducted online during November/December 2012 and January 2013. The survey, launched 16 years ago, had an unprecedented response from sites this year, with a total of 2,032 global sites responding.
In March, CenterWatch released the first part of this global study, in which investigative sites evaluated their relationships with pharmaceutical and biotechnology companies worldwide.
Contact Joan Chambers at (617) 948-5100 or email@example.com for information on receiving a comprehensive and detailed report of the results. Custom reports provide company-specific results compared with past survey findings and industry benchmarks. To read the full CRO report, subscribe to The CenterWatch Monthly or purchase the May issue.
Since 1994, CenterWatch, has been the recognized global leader in providing clinical trials information to a broad and influential spectrum of clinical research professionals ranging from top sponsors and CROs to research sites and niche providers, as well as an engaged population of patients interested in clinical research and volunteering. For more information, visit www.centerwatch.com.